The continuing evolution of HIV therapy.
D000225:Adenine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000480:Alkynes; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D023241:Antiretroviral Therapy, Highly Active / Q000009:adverse effects / Q000379:methods / Q000639:trends*; D000069446:Atazanavir Sulfate; D048588:Benzoxazines; D018791:CD4 Lymphocyte Count; D002219:Carbamates; D003521:Cyclopropanes; D003692:Delayed-Action Preparations; D003841:Deoxycytidine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D016049:Didanosine / Q000627:therapeutic use; D015224:Dideoxynucleosides / Q000627:therapeutic use; D016903:Drug Monitoring / Q000379:methods / Q000639:trends; D000068679:Emtricitabine; D005663:Furans; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D019259:Lamivudine / Q000627:therapeutic use; D019829:Nevirapine / Q000627:therapeutic use; D009842:Oligopeptides / Q000627:therapeutic use; D010755:Organophosphates / Q000627:therapeutic use; D063065:Organophosphonates; D009943:Organophosphorus Compounds / Q000627:therapeutic use; D010078:Oxazines / Q000627:therapeutic use; D011725:Pyridines / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic; D018119:Stavudine / Q000627:therapeutic use; D013449:Sulfonamides / Q000627:therapeutic use; D000068698:Tenofovir; D016896:Treatment Outcome; D019562:Viral Load; D015215:Zidovudine / Q000627:therapeutic use; D000099227:Abacavir
D000225:Adenine; D000480:Alkynes; D019380:Anti-HIV Agents; D000069446:Atazanavir Sulfate; D048588:Benzoxazines; D002219:Carbamates; D003521:Cyclopropanes; D003692:Delayed-Action Preparations; D003841:Deoxycytidine; D016049:Didanosine; D015224:Dideoxynucleosides; D000068679:Emtricitabine; D005663:Furans; D019259:Lamivudine; D019829:Nevirapine; D009842:Oligopeptides; D010755:Organophosphates; D063065:Organophosphonates; D009943:Organophosphorus Compounds; D010078:Oxazines; D011725:Pyridines; D018119:Stavudine; D013449:Sulfonamides; D000068698:Tenofovir; D015215:Zidovudine; D000099227:Abacavir; C098320:efavirenz; C426859:fosamprenavir